Condition
Delayed Sleep Phase Disorder
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07433491Not ApplicableNot Yet Recruiting
Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry
NCT01406691Phase 4RecruitingPrimary
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
NCT00950885Not ApplicableCompletedPrimary
Melatonin Treatment for Induced Transient Insomnia
Showing all 3 trials